- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07850245
The Effect of Different Auditory Types on Visual Evoked Potentials (VEP)
September 24, 2026 updated by: Kholoud Ahmad Bokhary, King Saud University
To investigate the effect of different sound types on pattern visual evoked potential (VEP) responses among healthy adults
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
68
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
(State)
-
Riyadh, (State), Saudi Arabia, 12372
- Kholoud Ahmad Bokhary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
the retina clinic at the Ophthalmology Department at King Abdulaziz University Hospital
Description
Inclusion Criteria:
- Healthy subjects with no ocular or systemic diseases
- Aged between 20 to 60 years
- Subjects with best corrected visual acuity (BCVA) 0.40 LogMAR or better
- Subjects with normal hearing
Exclusion Criteria:
- Subjects with ocular disorders or any neurodegenerative disorders, hearing impairment
- Patient with best visual acuity less than 0.40 LogMAR
- Patients taking neurotoxic drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: CROSS_SECTIONAL
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
VEP responses can be influenced by the auditory conditions during visual pathway assessment in healthy adults, with silence producing higher amplitudes than Quran recitation and music exposure at the 1° stimulation size
Time Frame: From January 2026 to June 2026
|
From January 2026 to June 2026
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
• Stimulation size may influence the sensitivity of VEP in detecting functional differences in the visual pathway, with significant correlation between BCVA and P100 amplitude observed during music exposure at 0.25°.
Time Frame: From January 2026 to June 2026
|
From January 2026 to June 2026
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 6, 2026
Primary Completion (Actual)
June 30, 2026
Study Completion (Actual)
June 30, 2026
Study Registration Dates
First Submitted
September 24, 2026
First Submitted That Met QC Criteria
September 24, 2026
First Posted (Actual)
September 30, 2026
Study Record Updates
Last Update Posted (Actual)
September 30, 2026
Last Update Submitted That Met QC Criteria
September 24, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-25-10435 date: 1 Jan.2026
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.